We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$80B
AUM Growth
+$3.78B
Cap. Flow
+$2.03B
Cap. Flow %
2.54%
Top 10 Hldgs %
13.93%
Holding
3,241
New
178
Increased
2,105
Reduced
536
Closed
137

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$80.9M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$66M
3
MRK icon
Merck
MRK
+$63.3M
4
PG icon
Procter & Gamble
PG
+$58.4M
5
IBM icon
IBM
IBM
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.8%
2 Technology 13.16%
3 Financials 12.69%
4 Industrials 10.65%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NL icon
3076
NLI Holdings
NL
$317M
$58K ﹤0.01%
22,201
-8,438
-28% -$24.1K
PRGX
3077
DELISTED
PRGX Global, Inc.
PRGX
$58K ﹤0.01%
11,000
HBIO icon
3078
Harvard Bioscience
HBIO
$29.2M
$56K ﹤0.01%
1,930
-7,493
-80% -$238K
QMCO icon
3079
Quantum Corp
QMCO
$474M
$53K ﹤0.01%
781
-4,300
-85% -$312K
REXX
3080
DELISTED
Rex Energy Corporation
REXX
$46K ﹤0.01%
6,961
-6,964
-50% -$58K
FLNA
3081
Filana Therapeutics
FLNA
$48.1M
$41K ﹤0.01%
2,657
ARQL
3082
DELISTED
Arqule Inc
ARQL
$40K ﹤0.01%
21,000
VXRT
3083
DELISTED
Vaxart
VXRT
$37K ﹤0.01%
2,365
AST
3084
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$37K ﹤0.01%
15,125
ALR
3085
DELISTED
AlerisLife Inc
ALR
$34K ﹤0.01%
1,434
-9,904
-87% -$214K
BDSI
3086
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$34K ﹤0.01%
14,119
-79,500
-85% -$219K
CBK
3087
DELISTED
Christopher & Banks Corporation
CBK
$30K ﹤0.01%
13,400
-51,800
-79% -$120K
HHS icon
3088
Harte-Hanks
HHS
$28K ﹤0.01%
1,720
-13,668
-89% -$241K
QUIK icon
3089
QuickLogic
QUIK
$257M
$27K ﹤0.01%
1,971
VVUS
3090
DELISTED
Vivus Inc
VVUS
$27K ﹤0.01%
2,340
-19,040
-89% -$263K
CASC
3091
DELISTED
Cascadian Therapeutics, Inc.
CASC
$25K ﹤0.01%
4,283
-25,285
-86% -$172K
IPI icon
3092
Intrepid Potash
IPI
$469M
$17K ﹤0.01%
1,180
-44,422
-97% -$561K
SPRT
3093
DELISTED
support.com, Inc.
SPRT
$16K ﹤0.01%
6,133
AVEO
3094
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$15K ﹤0.01%
1,510
OREX
3095
DELISTED
Orexigen Therapeutics, Inc.
OREX
$15K ﹤0.01%
3,275
-15,119
-82% -$68.4K
EGY icon
3096
Vaalco Energy
EGY
$594M
$14K ﹤0.01%
12,600
STCN
3097
DELISTED
Steel Connect, Inc. Common Stock
STCN
$13K ﹤0.01%
1,120
-6,289
-85% -$82.3K
MDGL icon
3098
Madrigal Pharmaceuticals
MDGL
$11.8B
$12K ﹤0.01%
1,254
-5,480
-81% -$65.7K
ONCT
3099
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$9K ﹤0.01%
11
CJES
3100
DELISTED
C&J ENERGY SVCS LTD
CJES
$7K ﹤0.01%
10,200
-137,918
-93% -$128K

Similar funds

Charles Schwab's Q2 2016 Portfolio in Review

As of Q2 2016, Charles Schwab held 3,241 positions worth $80B, up 5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2016 filing shows 178 new, 2,105 increased, 536 reduced and 137 closed positions. Its largest new stake was S&P Global: 753,915 shares worth $80.9M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Charles Schwab's largest Q2 2016 buy was S&P Global: 753,915 shares worth $80.9M.
  • Charles Schwab added most to Merck in Q2 2016, an estimated $63.3M increase.
  • Charles Schwab's biggest Q2 2016 reduction was Computer Sciences, cutting an estimated $61.8M.
  • Charles Schwab fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $178M.
  • Charles Schwab's ten largest holdings make up 14% of its $80B portfolio in Q2 2016.
  • Charles Schwab opened 178 new positions and closed 137 in Q2 2016.
  • Charles Schwab's portfolio value rose 5% quarter-over-quarter to $80B.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.